Pfizer, BioNTech Begin Clinical Trials Of Coronavirus Vaccine In Children Under 12

Pfizer, BioNTech Begin Clinical Trials Of Coronavirus Vaccine In Children Under 12

American pharmaceutical Pfizer and its German partner BioNTech SE have started the clinical trials of its coronavirus vaccine in children under 12, giving an early sign of the next stage of the integral immunisation campaign. “Together with our partner BioNTech, we have dosed the first healthy children in a integral Phase 1/2/3 continuous study to further evaluate the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine,” news agency AFP quoted the company as saying. Also Read – India Hasn’t Banned COVID-19 Vaccine Exports, Will Continue Supply to Partner Countries: Sources

As per the updates posted on the site, the company is testing three different dosing levels – 10, 20 and 30 micrograms – in a 144-participant Phase I/II trial for use in this age group, with hopes of expanding vaccination to that age range by early 2022. Also Read – CoWIN Portal Will No Longer Schedule Appointment For Your 2nd COVID-19 Vaccine Dose On Its Own

Pfizer and BioNTech also plan to later expand to a 4,500-participant late-stage trial in which they will test the safety, tolerability and immune response generated by the vaccine, likely by measuring antibody levels in the young subjects. Also Read – Sanjay Dutt Gets His First COVID-19 Jab, Shares a Proud Note on Social Media

After the clinical trial started, the first volunteers in the early-stage trial were given their first injections on Wednesday, Pfizer spokesperson Sharon Castillo said in a statement.

Pfizer is already testing the shots in children aged 12 to 15, and its US emergency authorisation covers people aged 16 and up. With this, Pfizer has joined Moderna and AstraZeneca in testing their vaccines in children as young as 6 months.

While the Pfizer-BioNTech vaccine is being used in 16- and 17-year-olds in the United States, Moderna’s vaccine was cleared for people above age 18.

(With inputs from agencies)

#Pfizer #BioNTech #Clinical #Trials #Coronavirus #Vaccine #Children

Leave a Comment